CymitQuimica logo

CAS 10514-70-2

:

Formula:C10H11NO2
InChI:InChI=1S/C10H11NO2/c1-10(2)9(12)11-7-5-3-4-6-8(7)13-10/h3-6H,1-2H3,(H,11,12)
InChI key:LJRUKUQEIHJTEL-UHFFFAOYSA-N
SMILES:CC1(C(=O)NC2=CC=CC=C2O1)C
Found 4 products.
  • 2,2-Dimethyl-3,4-dihydro-2H-1,4-benzoxazin-3-one

    CAS:
    2,2-Dimethyl-3,4-dihydro-2H-1,4-benzoxazin-3-one
    Formula:C10H11NO2
    Purity:>98%
    Molecular weight:177.19984

    Ref: 54-OR925185

    250mg
    32.00€
    1g
    61.00€
    5g
    185.00€
    25g
    821.00€
  • 2,2-Dimethyl-3,4-dihydro-2H-1,4-benzoxazin-3-one

    CAS:
    Formula:C10H11NO2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:177.1998

    Ref: IN-DA007FGC

    100mg
    28.00€
    250mg
    31.00€
  • 2,2-DIMETHYL-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

    CAS:
    Formula:C10H11NO2
    Purity:98%
    Molecular weight:177.203

    Ref: 10-F471149

    1g
    68.00€
  • 2,2-Dimethyl-3,4-dihydro-2H-1,4-benzoxazin-3-one

    CAS:

    2,2-Dimethyl-3,4-dihydro-2H-1,4-benzoxazin-3-one is a potential cancer drug that belongs to the family of bromodomain inhibitors. It inhibits the transcriptional activity of the androgen receptor by binding to its DNA binding domain. This binding prevents the formation of a transcriptionally active complex with other proteins that are required for gene expression. Bromodomain inhibition has been shown to be effective in vivo and in vitro against castration resistant prostate cancer cells. 2,2-Dimethyl-3,4-dihydro-2H-1,4-benzoxazin-3-one also has an oral bioavailability profile that is suitable for oral administration as a therapeutic agent. This drug also binds to the terminal domain of family members, which may lead to increased potency against these enzymes.

    Formula:C10H11NO2
    Purity:Min. 95%
    Molecular weight:177.2 g/mol

    Ref: 3D-KAA51470

    5g
    497.00€